← FDA DRUG APPROVALS

FDA ANDA · ANDA214473

ESOMEPRAZOLE MAGNESIUM

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA214473
TYPE
ANDA
ORIGINAL APPROVAL
2023-07-12
LATEST ACTION
2023-07-12
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Over-the-counter

Products

ESOMEPRAZOLE MAGNESIUMOver-the-counter
ESOMEPRAZOLE MAGNESIUM EQ 20MG BASE · TABLET, DELAYED RELEASE · ORAL

Approval history

2023-07-12UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →